Shasha et al., 2022 - Google Patents
Mechanisms of colorectal liver metastasis developmentShasha et al., 2022
View HTML- Document ID
- 14320171051428142655
- Author
- Shasha T
- Gruijs M
- van Egmond M
- Publication year
- Publication venue
- Cellular and Molecular Life Sciences
External Links
Snippet
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, largely due to the development of colorectal liver metastases (CRLM). For the establishment of CRLM, CRC cells must remodel their tumor-microenvironment (TME), avoid the immune system …
- 210000004185 Liver 0 title abstract description 78
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shasha et al. | Mechanisms of colorectal liver metastasis development | |
| Petty et al. | Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment | |
| Xiong et al. | Neutrophils in cancer carcinogenesis and metastasis | |
| Wang et al. | LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195 | |
| Swarts et al. | Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities | |
| Aleskandarany et al. | Molecular mechanisms underlying lymphovascular invasion in invasive breast cancer | |
| Takagi et al. | Platelets enhance multiple myeloma progression via IL-1β upregulation | |
| Popper | Primary tumor and metastasis—sectioning the different steps of the metastatic cascade | |
| CN103608037A (en) | Use of anti-DKK1 monoclonal antibody for treating liver cancer | |
| Zhang et al. | Loss of endothelial EMCN drives tumor lung metastasis through the premetastatic niche | |
| EP3615940B1 (en) | A method for determining myeloid natural killer (nk)-cells and use thereof | |
| Fuertes et al. | Noncanonical Wnt signaling promotes colon tumor growth, chemoresistance and tumor fibroblast activation | |
| Hanahan et al. | Hallmarks of cancer. An organizing principle for cancer medicine | |
| Selvaggi et al. | Wingless/It/β-catenin signaling in liver metastasis from colorectal cancer: A focus on biological mechanisms and therapeutic opportunities | |
| Thomas et al. | Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point? | |
| Ran et al. | Is a Key Promoter of Tumor Growth, Vascularization, and Metastasis | |
| Sánchez-Ramírez et al. | Impact of STAT-signaling pathway on cancer-associated fibroblasts in colorectal cancer and its role in immunosuppression | |
| Cheng et al. | Single‐cell and spatial omics unravel the spatiotemporal biology of tumour border invasion and haematogenous metastasis | |
| US20250201339A1 (en) | Use of combined cd274 copy number changes and tmb to predict response to immunotherapies | |
| McLean et al. | Tumor microenvironment and models of ovarian cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium | |
| Wen et al. | Tumor-associated neutrophils in breast cancer: an angel or a devil? | |
| Bouguerra et al. | Hepatectomy alters adjuvant anti-PD-1 action in a mouse model of HCC but does not compromise neoadjuvant efficacy | |
| Choi et al. | Context-dependent roles for autophagy in myeloid cells in tumor progression | |
| Lee | Hepatocytes Coordinate a Systemic Endocrine Network in Cancer | |
| US20240139197A1 (en) | Inhibition of kdm5a for promoting antigen presentation, increasing cd8+ t cell infiltration and boosting anti-tumor immune response |